The average P/S ratio for RMD's competitors is 4.98, providing a benchmark for relative valuation. Resmed Inc Corp (RMD) exhibits a P/S ratio of 5.87, which is 17.77% above the industry average. Given its robust revenue growth of 10.26%, this premium appears unsustainable.